Author: admin

Administrator

How to utilize Prescriptive Service to deliver ROI

Title: How to utilize Prescriptive Service to deliver ROI

Speaker: Ramki Pitchuiyer, CEO & co-founder

Date: 07/17/2018

Brief Description:

  • Ramki is the CEO & Co-Founder of eKryp, a Prescriptive Service application. eKryp targets aftermarket Service Operations. Prior to eKryp, Ramki co-founded Paloras. Ramki believes in connecting AI w/ Human intelligence to bring superior end customer experience. He has am MBA from the Anderson School, UCLA and a  B.S in Electrical Eng from BITS, Pilani in India.

Attachment

To see this content, please login

Protecting Intellectual Assets in the New World of U.S. IP Law

Title: Protecting Intellectual Assets in the New World of U.S. IP Law

Speaker:  Alper Ertas, JD, Venable, LLC

Date: 06/12/2018

Brief Description:
The landscape for IP protection in the United States has shifted significantly in the wake of lobbying, changes in federal laws, and precedential decisions from the Supreme Court and Federal Circuit. Many of these changes are in response to litigation practices used by non-practicing entities. Alper will discuss key changes to the laws governing patent and trade secret protection and how they affect IP strategy for developed and emerging companies in the biotech space.

Attachment:

To see this content, please login

The New Generation of Cerebral Aneurysm Therapy

Title:  The New Generation of Cerebral Aneurysm Therapy

Speaker: Claire Houston, Clinical Consultant for Pulsar Vascular

Date:  06/05/2018

Brief Description:
This program covered intracranial aneurysms and challenges associated with these difficult to treat lesions. Historically intracranial aneurysms were treated with open surgery but after 2003, embolic coiling became the preferred method of treatment. There have been significant advances regarding the use, safety, and efficacy of these devices however, these
lesions remain difficult to treat for the endovascular surgeon. Specifically, this program covered the multitude of requirements it takes to bring a novel product to market to replace or improve on the minimally invasive device currently available in the US and Europe.

Attachment:

To see this content, please login

Lean Startup – tactics and strategies for early stage medical device companies

Title: Lean Startup – tactics and strategies for early stage medical device companies

Speaker:  Evan Anderson, CEO, Luma Therapeutics

Date: 05/22/2018

Brief Description:
“Lean” is a popular concept in the startup world these days but there are few guidelines on how to implement it at a medical device company where hardware development is combined with a regulatory burden. I’ll share with you my personal tips/tricks for keeping the burn low while driving down risk.

Attachment:

To see this content, please login

Transforming the dental implant into a bio-engineered medical device

Title: Transforming the dental implant into a bio-engineered medical device

Speaker: Issa Karkar, DDS, CEO In Pronto

Date: 05/08/2018

Brief Description:
InPronto has removed the current fundamental disconnection in the process between implant surgery and the prosthetic fabrication and placement which may not function as intended might provide inferior results, and instead solves it holistically treating the tooth as complete device, from the root tip to the cusp tip, as nature intended it and thus delivering superior results. InPronto creates a paradigm shift transforming the dental implant into a medical device and simplifying the delivery process

Attachment:

To see this content, please login

Doing the Bio Biz in China – The challenges, the Rewards, and (more importantly) the Pitfalls

Title: Doing the Bio Biz in China – The challenges, the Rewards, and (more importantly) the Pitfalls

Speaker: Lu Wang – General Manager- Hefei Sageland Biotechnology

Date:  04/17/2018

Brief Description:
In this presentation, Dr. Wang will share with you the lessons he’s learned from his two successive attempts at the China Play, and some tips on how to maximize the return from such an endeavor. It begins with some historical and cultural context, then on to some practical consideration about starting an operation there. Towards the end of the talk, he will also cover Flow Pharma’s technology and its clinical activities in China, as well as some suggestions about working within China’s ever-changing regulatory environment.

Attachment:

To see this content, please login

The Past, Present and Future of Fetal Monitoring

Title: The Past, Present and Future of Fetal Monitoring

Speakers:  Neil Ray, M.D., Mark Rosen, M.D.

Date: 04/10/2018

Brief Description:
Civilizations have been monitoring babies during pregnancy since the times of the Egyptians. We will examine some of the methods used in the past for fetal monitoring as well as the reasons why babies were monitored. We will discuss the current methods for fetal monitoring, the limitations as well as the consequences. Finally, we will discuss the novel fetal monitoring technology that Raydiant Oximetry is developing and how this technology could improve outcomes for mothers and babies during childbirth.

Attachment:

To see this content, please login

Deep learning and its application in Medicine

Title: Deep learning and its application in Medicine

Speaker: Ravi Chityala, Senior Engineer, Elekta

Date:  04/03/2018

Brief Description:
In the last 10 years, much progress has been made with Neural Networks and Deep Learning due to accelerated computer power (GPUs) and availability of Open Source libraries. This talk will delve into some of these technologies and how they help accelerate.

Attachment:

To see this content, please login

Wearable Devices from Idea to FDA Approval

Title: Wearable Devices from Idea to FDA Approval

Author: Walt Maclay – President, Voler Systems

Date: 03/13/2018

Brief Description:
Walt Maclay discussed the issues involved with bringing wearable medical devices from an idea to FDA approval. He discussed areas including different sensing technologies, battery life, data security, and meeting FDA and CE requirements.

Attachment:

To see this content, please login